Movatterモバイル変換

[0]ホーム
URL:

Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Medknow Publications and Media Pvt Ltd full text link Medknow Publications and Media Pvt Ltd Free PMC article
Full text links

Actions

Share

.2013 Apr;55(2):178-82.
doi: 10.4103/0019-5545.111459.

Clinical risk of stigma and discrimination of mental illnesses: Need for objective assessment and quantification

Affiliations

Clinical risk of stigma and discrimination of mental illnesses: Need for objective assessment and quantification

Amresh Shrivastava et al. Indian J Psychiatry.2013 Apr.

Abstract

Stigma and discrimination continue to be a reality in the lives of people suffering from mental illness, particularly schizophrenia, and prove to be one of the greatest barriers to regaining a normal lifestyle and health. Research advances have defined stigma and assessed its implications and have even examined intervention strategies for dealing with stigma. We are of the opinion that stigma is a potential clinical risk factor. It delays treatment seeking, worsens course and outcome, reduces compliance, and increases the risk of relapse; causing further disability, discrimination, and isolation even in persons who have accessed mental health services. The delay in treatment due to stigma causes potential complications like suicide, violence, harm to others, and deterioration in capacity to look after one's physical health. These are preventable clinical complications. In order to deal with the impact of stigma on an individual basis, it needs to be (i) assessed during routine clinical examination, (ii) assessed for quantification in order to obtain measurable objective deliverables, and (iii) examined if treatment can reduce stigma and its impact on individuals. New and innovative anti-stigma programs are required that are clinically driven in order to see the change in life of an individual by removing potential risks. The basic requirement for dealing with an individual's stigma perception/experience is its proper assessment for origin and impact in both a qualitative and quantitative manner. We further argue that quantification would allow for regular assessment and offer more effective intervention for patients. It will also be helpful in identifying modifiable social factors to enhance quality of care planning for management in hospitals and communities. The objective of quantification is to facilitate developing an approach to bring the assessment of stigma into clinical work and formulating customized strategies to deal with stigma at the patient level. It would be expected that the assessment of stigma would become a part of routine clinical assessment to identify barriers to outcome. This article discusses the need for quantification of patients' experiences of mental illness stigma.

Keywords: Mental illness; quantification; risk factor; schizophrenia; stigma.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared

Similar articles

See all similar articles

Cited by

References

    1. Murthy RS. Stigma is universal but experiences are local. World Psychiatry. 2002;1:28. - PMC - PubMed
    1. Franz L, Carter T, Leiner AS, Bergner E, Thompson NJ, Compton MT. Stigma and treatment delay in first-episode psychosis: A grounded theory study. Early Interv Psychiatry. 2010;4:47–56. - PMC - PubMed
    1. Sartorius N. Need for paradigm shift in dealing with stigma. World Congress of Psychiatry, Personal communication. 2009
    1. Shrivastava A, Sakhel G. Study of stigma and discrimination in Schizophrenia in Mumbai. Indian J Psychiatry. 2002;44:85–6.
    1. McGlashan TH. Is active psychosis neurotoxic? Schizophr Bull. 2006;32:609–13. - PMC - PubMed

Related information

LinkOut - more resources

Full text links
Medknow Publications and Media Pvt Ltd full text link Medknow Publications and Media Pvt Ltd Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.

[8]ページ先頭
©2009-2025 Movatter.jp